HPV-RELATED ADENOSQUAMOUS CARCINOMA
Clinical trials for HPV-RELATED ADENOSQUAMOUS CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HPV-RELATED ADENOSQUAMOUS CARCINOMA trials appear
Sign up with your email to follow new studies for HPV-RELATED ADENOSQUAMOUS CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental immune therapy aims to tackle HPV cancers before standard care
Disease control Recruiting nowThis study tests whether a single infusion of a patient's own genetically engineered immune cells (E7 TCR-T cells) can shrink or eliminate HPV-related cancers before the patient receives standard treatment like chemo-radiation or surgery. The trial enrolls 15 adults with advanced…
Matched conditions: HPV-RELATED ADENOSQUAMOUS CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Christian Hinrichs • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Supercharged immune cells take on HPV cancers
Disease control Recruiting nowThis study tests a new immunotherapy for people with advanced HPV-related cancers, such as cervical, throat, anal, and penile cancers. Participants receive specially engineered immune cells designed to attack cancer cells carrying the HPV16 virus. The goal is to see if this treat…
Matched conditions: HPV-RELATED ADENOSQUAMOUS CARCINOMA
Phase: PHASE2 • Sponsor: Christian Hinrichs • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC